Held as a fully online, virtual experience from March 9 to 14, AD/PD 2021 was a six-day academic conference that focused on topics including newest research breakthroughs, drug research and development, early diagnosis, and clinical studies around Alzheimer’s and Parkinson’s diseases and related neurological disorders. During the conference, Green Valley Pharmaceuticals hosted a virtual seminar themed “Dysbiosis of Gut Microbiota in the Parkinson’s Disease, a Novel Perspective of Diagnosis and Intervention”, inviting three experts from both home and abroad to share the latest research findings and conduct in-depth discussions.